Anzeige
Mehr »
Login
Donnerstag, 24.04.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Gamechanger-Deal am Horizont: Entscheidende Nachrichten in 2025 erwartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 866993 | ISIN: US6541061031 | Ticker-Symbol: NKE
Tradegate
24.04.25
09:58 Uhr
50,15 Euro
-0,52
-1,03 %
1-Jahres-Chart
NIKE INC Chart 1 Jahr
5-Tage-Chart
NIKE INC 5-Tage-Chart
RealtimeGeldBriefZeit
50,0150,1509:59
50,0150,1509:58
PR Newswire
247 Leser
Artikel bewerten:
(1)

Decentralized Biotechnology Intelligence Holding Group Inc.: Former Nike VP & GM Bert Hoyt Joins dBio to Drive Next-Gen Sports & Health Tech as Board Advisor

Finanznachrichten News

LUXEMBOURG, April 24, 2025 /PRNewswire/ -- Decentralized Biotechnology Intelligence Holding Group Inc. (dBio), a leading innovator in sports and health tech, delivering advanced wearable AIoT solutions that seamlessly merge athletic performance monitoring with real-time health insights, is pleased to announce Hubertus "Bert" Hoyt as its newest Board Advisor.

Bert Hoyt, Former Nike VP & GM, Joins dBio as Board Advisor to Drive Innovation in Athlete Performance and Wellness

Bert is a renowned sports industry expert with over 32 years of experience. His extensive background working with some of the world's most iconic sports brands and elite athletes will bring invaluable strategic insights to dBio's Board, supporting its mission to revolutionize personalized healthcare and fitness technologies worldwide.

dBio: Leading the Future of Health and Exercise Management

Dedicated to empowering individuals to better understand their bodies, dBio helps users optimize training, accelerate recovery, and reduce injury risk through personalized, data-driven feedback.

At the core of dBio's platform are its proprietary technologies: gMOTCloud, the original AI-powered kinesiology wearable capturing detailed motion and gait metrics, and StethoCloud, a lightweight wearable stethoscope enabling continuous heart and respiratory monitoring with AI-enhanced noise reduction. Collectively, these devices offer cloud-based analytics and virtual coaching support for healthier, safer, and more effective performance in exercise.

gMOTCloud by dBio - The original AI-powered kinesiology wearable that captures detailed motion and gait metrics to optimize performance. Engineered by experts, perfected by athletes, and designed for you

With more than 75 registered patents and a fully self-developed ecosystem spanning AI modeling, hardware, software, and app development, dBio delivers a comprehensive solution for performance optimization and health management, suitable for elite athletes to fitness enthusiasts, and across applications in telemedicine, rehabilitation, and elder care. Further, dBio's technology is supported by strategic partnerships with leaders across the medical, academic, and athletic sectors. As dBio continues to expand its global footprint, it aims to redefine the future of personalized health and performance technology.

Hubertus "Bert" Hoyt: A Proven Innovator in Global Brand Building

Bert began his career in 1989 at Puma, where he rose through the ranks from product management to business leadership for the brand. He eventually served as General Manager of Puma International, playing a key role in driving the company's exceptional growth between 1992 and 1998.

In 1998, Bert joined Nike, where he spent 22 years as a senior executive. His leadership roles spanned brand management, business unit general management, and global category management, culminating in nine years as Vice President & General Manager of Nike Western Europe and EMEA. Bert was instrumental in transforming Nike Germany, Global Football, and Western Europe, ultimately leading Nike EMEA to market leadership.

He is particularly known for his deep understanding of consumer needs and his ability to align teams to a clear and compelling consumer vision. Bert's unwavering focus on serving athletes with the best products and brand experiences helped Nike Western Europe grow from US$3 billion to US$7 billion, with EMEA reaching over US$10 billion in revenue and achieving a 24% EBIT.

Since his retirement from Nike in early 2021, Bert has served as a non-executive Director at JD Sports PLC, Crius Bidco Limited (owner of Zelus Sport Limited, a Nike licensee), Mast-Jaegermeister SE, and Cosnova GmbH (Beauty & Makeup). In addition to his impressive corporate career, Bert is a former ATP tennis professional, competing from 1977 to 1984.

"During my personal and business life I have been involved in helping athletes improve their performance and overall well-being. That's why I decided to join dBio as an Advisor, as I believe their innovations will provide that next chapter for athlete performance and provide sports enthusiasts the precise data to improve and help them manage their overall well-being."

Photo - https://mma.prnewswire.com/media/2668066/Image_2.jpg
Photo - https://mma.prnewswire.com/media/2668067/Image_1.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/former-nike-vp--gm-bert-hoyt-joins-dbio-to-drive-next-gen-sports--health-tech-as-board-advisor-302432680.html

© 2025 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.